Skip to main content
. 2016 Mar 17;12(8):2106–2112. doi: 10.1080/21645515.2016.1164376

Figure 2.

Figure 2.

Serum neutralizing titers (NT50) in (A) epithelial (ARPE-19) and (B) fibroblast (MRC-5) cells vs ELISA titers (AD-2 peptides 5, 6, and 7) from the epidemiological study. Correlations were highly significant (p ≤ 0.01), but most of the variability in neutralization is not predicted by AD-2 peptide ELISA (R2 = 0.06, 0.07).